Physical Exercise in Patients With Schizophrenia
Effect of Physical Strength Exercise on Telomeric Length as a Marker of Aging and Early Death in Patients With Schizophrenia
1 other identifier
interventional
40
1 country
1
Brief Summary
Randomised clinical trial on a cohort of subjects with a diagnosis of schizophrenia of legal age, of both sexes, recruited in the mental health clinics of the Salamanca University Assistance Complex and who will be randomly distributed into two groups (intervention and control). The main objective of the study is to determine the effect of physical exercise on telomere size in patients diagnosed with schizophrenia. As secondary objectives in this group of patients we will try to: Evaluate the influence of strength training on cognition and negative symptoms of schizophrenia. To quantify the impact of strength training on frailty. To determine the effect of strength training on quality of life. To study the possible correlation between physical parameters (frailty) and telomere length. To establish the importance of polymorphisms in telomerase genes, an enzyme involved in the maintenance of telomere length.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Mar 2024
Shorter than P25 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2023
CompletedFirst Posted
Study publicly available on registry
August 7, 2023
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedJanuary 22, 2024
January 1, 2024
1 month
July 17, 2023
January 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Telomere Length
Telomere length will be measured before and after the procedure in kilobases.
Baseline and immediately after the intervention
Secondary Outcomes (7)
Date of birth
Baseline
Sex
Baseline
Heighth
Baseline
Negative Symptoms
Baseline and immediately after the intervention
Fragility
Baseline and immediately after the intervention
- +2 more secondary outcomes
Study Arms (2)
Intervention group
EXPERIMENTALAn additional strength training programme will be carried out for 12 weeks with 2 sessions per week. The sessions will last approximately 50 minutes and will be divided into 3 distinct parts: The first part will consist of a warm-up with a part of aerobic exercise that will last approximately 15 minutes. This will be followed by the main part of strength training with a circuit of 6 exercises (3 series x 12 repetitions) which will last approximately 25 minutes. Finally, there will be a cool down phase with breathing exercises to allow people to recover.
Control group
SHAM COMPARATORSubjects in the control group will continue with their normal life and carry out all the activities they have been doing previously.
Interventions
12 multi-joint strength exercises will be developed. Participants will be taught the rating scale of perceived exertion (RPE) based on the number of repetitions in reserve (RIR). Participants will be asked that during the performance of each of the exercises they must perceive an effort between 7-8 within the overall score of the scale (0-10; 0 = no effort at all and 10 = cannot perform one more repetition, i.e. maximal effort). When subjects perform the 12 repetitions with lower perceived exertion than the set effort in two consecutive sessions with full range of motion the training load will be increased by about 2-10% following the American College of Sports Medicine guidelines and reassessed using the RIR-based RPE. Patients in the usual treatment group will continue to participate in their existing rehabilitation programmes, but will not be included in the strength training programme.
Normal life and carry out all the activities they have been doing previously.
Eligibility Criteria
You may qualify if:
- be at least 18 years of age
- have been diagnosed with schizophrenia for at least 5 years
You may not qualify if:
- are unable to read and understand the patient information sheet and sign the informed consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidad de Salamanca
Salamanca, Castilla Y León / Salamanca, 37007, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The persons in charge of the evaluation of the participants will be unaware of the assignment of the participants.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator. Juan Luis Sánchez González
Study Record Dates
First Submitted
July 17, 2023
First Posted
August 7, 2023
Study Start
March 1, 2024
Primary Completion
April 1, 2024
Study Completion
May 1, 2024
Last Updated
January 22, 2024
Record last verified: 2024-01